Outset Medical (OM) insider amends Form 3 to add option holdings

Rhea-AI Filing Summary

Outset Medical, Inc. insider ownership has been updated in an amended Form 3. The amendment reflects indirect holdings by BML Investment Partners, L.P., including short put options tied to 617,500 and 110,000 shares of Outset Medical and 1,902,201 shares of common stock. The filing states these derivative securities were previously omitted due to a clerical error.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Leonard Braden Michael

(Last) (First) (Middle)

65 E CEDAR - SUITE 2

(Street)

ZIONSVILLE IN 46077

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/12/2026

3. Issuer Name and Ticker or Trading Symbol
Outset Medical, Inc. [ OM ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)
02/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,902,201	I	Holdings of BML Investment Partners, L.P.(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Short Put Options (potential obligation to buy)(2)	02/12/2026	05/15/2026	Common Shares	617,500	$5	I	Holdings of BML Investment Partners, L.P.(1)
Short Put Options (potential obligation to buy)(2)	02/12/2026	05/15/2026	Common Shares	110,000	$2.5	I	Holdings of BML Investment Partners, L.P.

Explanation of Responses:

1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

2. This filing is being updated to include the derivative securities that were omitted in the original due to a clerical error.

	Braden M Leonard	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the amended Form 3 for Outset Medical (OM) report?

The amended Form 3 updates reported holdings for a major Outset Medical shareholder. It adds derivative securities, specifically short put options, and confirms indirect ownership of common stock through BML Investment Partners, L.P., correcting an earlier clerical omission.

Who is the reporting person in Outset Medical (OM)'s amended Form 3?

The reporting person is Leonard Braden Michael, identified as a ten percent owner of Outset Medical. His reported holdings are indirect, through BML Investment Partners, L.P., with BML Capital Management, LLC serving as the general partner managing investment and voting control.

How many Outset Medical (OM) common shares are indirectly held?

The amended filing shows indirect ownership of 1,902,201 Outset Medical common shares. These shares are held by BML Investment Partners, L.P., a fund for which BML Capital Management, LLC acts as general partner exercising investment and voting control over the position.

What derivative positions are disclosed in Outset Medical (OM)'s amended Form 3?

The amendment discloses short put options referencing 617,500 and 110,000 Outset Medical shares. These options reflect potential obligations to buy shares and are held indirectly through BML Investment Partners, L.P., and were omitted in the original filing due to clerical error.

Does Leonard Braden Michael claim full beneficial ownership of OM shares?

The filing states Leonard Braden Michael may be regarded as beneficial owner through his control of BML Capital. However, he expressly disclaims beneficial ownership of the Outset Medical shares, except to the extent of his pecuniary interest in BML Investment Partners, L.P.

Why was Outset Medical (OM)'s Form 3 amended?

The Form 3 was amended to add derivative securities that were omitted previously. The footnotes explain the update was necessary because certain short put option positions held via BML Investment Partners, L.P. had been left out of the original Form 3 due to a clerical error.